Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
Public ClinicalTrials.gov record NCT00073047. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Placebo-controlled, Multi-center, Dose-ranging Study of Intravenous Daclizumab in Patients With Moderate-to-severe Ulcerative Colitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of The PROSPECT Study is to evaluate an investigational medication for the treatment of moderate to severe ulcerative colitis. This study is being conducted at up to 38 clinical research centers in the US, Canada, and Belgium, and is open to male and female patients 12 years and older. Participants in the study will have a number of visits to a research center over a five-month period. All study related care and medication is provided to qualified participants at no cost: this includes all visits, examinations, and laboratory work.
Study identification
- NCT ID
- NCT00073047
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 150 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2003 (Type not available)
- Primary completion
- Not listed
- Completion
- Jul 2006 (Actual)
- Last update posted
- Jul 20, 2009
2003 – 2006
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Associates | Huntsville | Alabama | 35801 | — |
| Advanced Medical Research Institute | Anaheim | California | 92801 | — |
| Research Foundation of America | Los Angeles | California | 90035 | — |
| Western Gastroenterology Group | Los Angeles | California | 90045 | — |
| Cedar Sinai Medical Center | Los Angeles | California | 90048 | — |
| GVAMC | Gainesville | Florida | 32608 | — |
| Clinical Research Associates | Hollywood | Florida | 33021 | — |
| Physician Office | Jacksonville | Florida | 32256 | — |
| Mount Sinai Medical Center | North Miami Beach | Florida | 33162 | — |
| Atlanta Gastroenterology Associates | Atlanta | Georgia | 30342 | — |
| The University of Chicago Hospital | Chicago | Illinois | 60637 | — |
| University of Kentucky Chandler Medical Center | Lexington | Kentucky | 40536 | — |
| Drug Research Services, Inc. | Metairie | Louisiana | 70001 | — |
| Medlantic Investigators Network | Annapolis | Maryland | 21401 | — |
| St. Louis Center for Clinical Research | St Louis | Missouri | 63128 | — |
| Long Island Clinical Research Associates | Great Neck | New York | 11021 | — |
| New York Center for Clinical Research | Lake Success | New York | 11042 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| Consultants for Clinical Research | Cincinnati | Ohio | 45219 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195-0001 | — |
| Oklahoma Foundation for Digestive Research | Oklahoma City | Oklahoma | 73104 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15261 | — |
| Columbia Gastro Associates | Columbia | South Carolina | 29203 | — |
| Memphis Gastroenterology Group, P.C. | Memphis | Tennessee | 38120 | — |
| Nashville Medical Research | Nashville | Tennessee | 37205 | — |
| Fletcher Allen Health Care | South Burlington | Vermont | 05041 | — |
| Digestive and Liver Disease Specialists | Norfolk | Virginia | 23502 | — |
| Richmond GI Research Group | Richmond | Virginia | 23230 | — |
| McGuire DVAMC | Richmond | Virginia | 23249 | — |
| Wisconsin Center for Advanced Research | Milwaukee | Wisconsin | 53207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00073047, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 20, 2009 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00073047 live on ClinicalTrials.gov.